dc.contributor.author | Manickavasagar, T | |
dc.contributor.author | Yuan, W | |
dc.contributor.author | Carreira, S | |
dc.contributor.author | Gurel, B | |
dc.contributor.author | Miranda, S | |
dc.contributor.author | Ferreira, A | |
dc.contributor.author | Crespo, M | |
dc.contributor.author | Riisnaes, R | |
dc.contributor.author | Baker, C | |
dc.contributor.author | O'Brien, M | |
dc.contributor.author | Bhosle, J | |
dc.contributor.author | Popat, S | |
dc.contributor.author | Banerji, U | |
dc.contributor.author | Lopez, J | |
dc.contributor.author | de Bono, J | |
dc.contributor.author | Minchom, A | |
dc.date.accessioned | 2021-06-03T09:39:46Z | |
dc.date.available | 2021-06-03T09:39:46Z | |
dc.date.issued | 2021-04-09 | |
dc.identifier | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000638291500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9 | |
dc.identifier | ARTN LMT48 | |
dc.identifier.citation | LUNG CANCER MANAGEMENT, 2021, pp. ? - ? (12) | |
dc.identifier.issn | 1758-1966 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4597 | |
dc.identifier.eissn | 1758-1974 | |
dc.identifier.doi | 10.2217/lmt-2020-0031 | |
dc.format.extent | ? - ? (12) | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | FUTURE MEDICINE LTD | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Respiratory System | |
dc.subject | ERBB3 | |
dc.subject | HER3 | |
dc.subject | MEK | |
dc.subject | NSCLC | |
dc.title | HER3 expression and MEK activation in non-small-cell lung carcinoma | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2021-02-22 | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.2217/lmt-2020-0031 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
rioxxterms.licenseref.startdate | 2021-04-09 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | LUNG CANCER MANAGEMENT | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Pharmacology – Adaptive Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology/Thoracic Oncology (hon.) | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Pharmacology – Adaptive Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Thoracic Oncology/Thoracic Oncology (hon.) | |
pubs.publication-status | Published | |
pubs.embargo.terms | Not known | |
icr.researchteam | Clinical Pharmacology – Adaptive Therapy | |
icr.researchteam | Thoracic Oncology | |
icr.researchteam | Clinical Pharmacology – Adaptive Therapy | en_US |
icr.researchteam | Thoracic Oncology | en_US |
dc.contributor.icrauthor | Banerji, Udai | en |
dc.contributor.icrauthor | Popat, Sanjay | en |